Navigation Links
Lutronic Inc. Announces FDA Clearance of Its Spectra VRM III Q-Switched Nd: Yag Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions
Date:5/20/2008

be the most valuable investment made by any dermatologist, plastic surgeon, or facial plastic surgeon. Its simplicity and safety are opening doors to other emerging markets where results, absence of discomfort, and zero downtime are required."

About Lutronic

Lutronic is one of the world's leading manufacturers of medical laser systems serving the clinical dermatological and aesthetic communities. With over a decade of award-winning technology design that includes its Spectra line of products and its unparalleled MOSAIC Systems, the company is committed to delivering innovative, highly effective, and painless laser solutions. Strategically headquartered in Princeton Junction, NJ (on the Route 1 corridor between New York City and Philadelphia), Lutronic Inc. maintains an extensive national network of distributors, including MedEdge, Elite Medical, and Aesthetic Technologies of Florida. In addition, Lutronic Inc. offers an impressive service department featuring experienced laser engineers who provide the highest level of service and support to physicians across the US. Manufacturing medical laser systems for markets in Europe and Asia, parent Lutronic Co. Ltd. is based in Seoul, South Korea and delivers product to over 40 countries. To learn more about the Spectra VRM III, please visit http://www.lutronic.com.

Contact:

Ken Reich

Director, Marketing & Public Relations

Lutronic, Inc.

Phone: 609 275-1565 x302 or 888 588-7644

Fax: 609 275-3800

Email: kreich@lutronicusa.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Lutronic Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
2. Best Practices Insurance Services Announces Key Additions to Senior Management
3. Bayer Announces Availability of Reformulated Liquid Leukine(R)
4. MediVoice Announces Appointment of Edward J. Zecchini as Chief Operating Officer & Chief Technology Officer
5. Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications
6. Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd
7. AMDL Announces Teleconference and Audio Web Conference to Discuss First Quarter Financial Results
8. MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
9. Environmental Tectonics Corporation Announces Sale of Two Hyperbaric Monoplace Chambers
10. DATATRAK Announces Restructured Senior Management Team
11. Spirus Medical Announces 510(k) Clearance from FDA for Expanded Use of Endo-Ease(R) Discovery SB(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
(Date:12/4/2009)Research and surveillance urged for at-risk patient groups , , FRIDAY, Dec. 4 (HealthDay News) -- Some childhood cancers, particularly Ewing sarcomas and central nervous system tumors, carry t
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2
...w insights into the role of estrogen receptor in m...r understand the molecular origin of breast cancer... Cincinnati (UC). , About a decade ago, U.S. sci...ors role in human diseases. , Unfortunately, beca...
...N, Sept. 5 On Friday, August 31, 2007, the First,... lawsuit brought by Maine,residents against Philip...ument that the claims were preempted by federal la...lleging that,Philip Morris, USA, Inc., and its par...
... Nurses Fight Healthcare Takeaways, Win Better Pat...nd Pay 10,000 CHW RNs in 25 Facilities Set to B... Some 3,500 registered nurses,at nine Southern Ca...urses Association announced today. The agreement,...
... children of affected Holocaust survivors showed h...(HealthDay News) -- Adults whose mother or father ...) often experience the biological signs of PTSD th...rvivors with PTSD. , A team of researchers from t...
...veries could lead to new treatments for autoimmune...ept. 5 (HealthDay News) -- Two genes boost the ris... also increases the odds for lupus, according to t...atoid arthritis or lupus, both of which are autoim...
...N, Va., Sept. 5 The National Association for Spor... today announced a new,partnership to help to educ...lop the knowledge, skills and attitudes for a heal...omoting this,comprehensive health-related fitness ...
Other Medicine News:Health News:New 'knock-out' gene model provides molecular clues to breast cancer 2Health News:New 'knock-out' gene model provides molecular clues to breast cancer 3Health News:First Circuit Court of Appeals Rules Against Philip Morris in 'Lights' Class Action 2Health News:RNs at Nine Catholic Healthcare West Hospitals Reach Agreement on New Master Pact 2Health News:Parents' PTSD May Boost Stress in Offspring 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 2Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 3Health News:Genes Boost Risk for Rheumatoid Arthritis, Lupus 4Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 2Health News:National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Children's Fitness 3
(Date:12/4/2009)INDIANAPOLIS, Dec. 4 The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes
(Date:12/4/2009)Workers Ensure Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. 4 Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public abo
(Date:12/4/2009)DURHAM, N.C., Dec. 4 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced that the first patient has been enrolled in the company,s Phase II-b, dose escalation, clinical trial in S
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 1Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 4Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 5Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 6Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 7Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 8Gene Mutation Could Be Key to Rare Blood Vessel Disease 52456 1Gene Mutation Could Be Key to Rare Blood Vessel Disease 52456 2Gene Mutation Could Be Key to Rare Blood Vessel Disease 52456 3Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech Inc Sales in Emerging Markets 13155 1Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech Inc Sales in Emerging Markets 13155 2Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech Inc Sales in Emerging Markets 13155 3
...d Muscle Society International Congress, SOUTH PL...TC), a biopharmaceutical company focused on the di...l-molecule drugs targeting,post-transcriptional co...from a Phase 2 clinical trial of PTC124 in patient...nonsense mutation. The results, which include data...
... Trial Results of First Pro-Healing Stent Also ...ONG KONG, Oct. 18 OrbusNeich,s Genous(TM),Bio-eng...ions about,innovation in interventional cardiology...catheter Cardiovascular Therapeutics symposium, TC...on Convention Center in,Washington, D.C. The line...
Other Medicine Technology:PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007 2
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: